Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cizzle Biotechnology HoldingsLSE:CIZ -2.63% Days Inventory is 0.00 as of Dec. 2025. The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Cizzle Biotechnology Holdings ranks worse than 156739.66% on this metric.
The historical rank and industry rank for Cizzle Biotechnology Holdings's Days Inventory or its related term are showing as below:
During the past 13 years, Cizzle Biotechnology Holdings's highest Days Inventory was 3817.70. The lowest was 84.60. And the median was 1951.15.
LSE:CIZ's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 182.6 * Ranked among companies with meaningful Days Inventory only.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cizzle Biotechnology Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cizzle Biotechnology Holdings (LSE:CIZ) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cizzle Biotechnology Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cizzle Biotechnology Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cizzle Biotechnology Holdings Days Inventory Related Terms
Cizzle Biotechnology Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cizzle Biotechnology Holdings Days Inventory Chart
LSE:CIZ vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Cizzle Biotechnology Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cizzle Biotechnology Holdings Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cizzle Biotechnology Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cizzle Biotechnology Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cizzle Biotechnology Holdings (LSE:CIZ) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cizzle Biotechnology Holdings and its competitors. Over the past decade, Cizzle Biotechnology Holdings' Days Inventory has ranged from 84.60 to 3,817.70. According to the industry distribution chart, Cizzle Biotechnology Holdings ranks #999999 out of 638 companies in the Biotechnology industry.
Is Cizzle Biotechnology Holdings' Days Inventory too high?
Cizzle Biotechnology Holdings' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 84.60 to a high of 3,817.70. Based on the distribution chart, Cizzle Biotechnology Holdings ranks #999999 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Cizzle Biotechnology Holdings' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cizzle Biotechnology Holdings ranks #999999 out of 638 companies for Days Inventory. This places Cizzle Biotechnology Holdings in the lower half of its industry. The industry median Days Inventory is 182.60. Historically, Cizzle Biotechnology Holdings' own Days Inventory has ranged from 84.60 to 3,817.70 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 182.60, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cizzle Biotechnology Holdings and its competitors. For the Biotechnology industry, the median Days Inventory is 182.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cizzle Biotechnology Holdings's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cizzle Biotechnology Holdings stock overvalued right now?
Cizzle Biotechnology Holdings (LSE:CIZ) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cizzle Biotechnology Holdings (LSE:CIZ), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cizzle Biotechnology Holdings PLC is a holding company of a group of companies (the Group) whose principal activity is the early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. Designed as a simple blood test, it enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:CIZ has been successfully added to your 
